Aterian Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $34.2M-65.5% YoYTTM through 30 Jun 2026
Net Income -$16.9MTTM through 30 Jun 2026
Free Cash Flow -$2.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 56.8% |
| EBITDA Margin | -49.1% |
| Operating Margin | -26.1% |
| Net Margin | -49.3% |
Returns
-124.8%ROE
-64.2%ROA
Balance Sheet Health
Debt / Equity0.30x
Current Ratio1.70x
Net Debt-$230Knet cash position
Cash & Equivalents$2.5M
Quality Metrics
Altman Z-Score-43.70
Piotroski F-Score2 / 9
FCF Margin-7.6%
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $69M
Diluted EPSFY2025: $-2.39
Dividend
No dividend
Capital Allocation
Capex Intensity0.2%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.